SBS 371
Alternative Names: SBS-371Latest Information Update: 03 Mar 2023
At a glance
- Originator Sparian Biosciences
- Class Drug withdrawal therapies
- Mechanism of Action Opioid mu receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Opioid-related disorders
Most Recent Events
- 21 Feb 2023 Early research in Opioid-related disorders (Prevention) in USA (IV) (Sparian Biosciences pipeline, February 2023)
- 21 Feb 2023 Early research in Opioid-related disorders in USA (IV) (Sparian Biosciences pipeline, February 2023)
- 21 Feb 2023 Early research in Opioid-related disorders in USA (SC) (Sparian Biosciences pipeline, February 2023)